NASDAQ:ADMP
Adamis Pharmaceuticals Corporation
- Stock
Last Close
0.77
07/09 19:59
Market Cap
7.25M
Beta: 1.23
Volume Today
119.48K
Avg: 1.54M
PE Ratio
−0.12
PFCF: −0.54
Mar '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 471.03K - | 1.38M 193.68% | 2.55M 84.47% | 2.67M 4.63% | 2.59M 3.05% | 1.77M 31.73% | 828.69K 53.11% | |||
average payables | 1.55M - | 584.41K 62.33% | 1.32M 126.59% | 2.53M 91.43% | 3.54M 39.85% | 4.22M 19.02% | 3.88M 8.05% | 3.62M 6.62% | 5.85M 61.36% | |
average receivables | 402.69K - | 817.73K 103.07% | 992.63K 21.39% | 1.52M 52.77% | 1.49M 2.05% | 3.50M 135.41% | 3.49M 0.11% | |||
book value per share | 116.14 - | 49.11 57.71% | 101.12 105.89% | 97.65 3.43% | 83.62 14.37% | 47.36 43.36% | 3.16 93.34% | 12.57 298.20% | -0.01 100.04% | |
capex per share | -95.29 - | -0.48 - | -5.16 964.90% | -6.33 22.75% | -3.77 40.50% | -0.85 77.33% | -0.59 30.43% | -0.00 99.24% | ||
capex to depreciation | -33.77 - | -0.05 - | -0.68 1,327.20% | -1.14 67.30% | -0.97 14.67% | -0.26 73.05% | -0.85 224.84% | -0.46 46.18% | ||
capex to operating cash flow | 1.47 - | 0.01 - | 0.14 2,312.15% | 0.11 21.58% | 0.14 33.15% | 0.05 68.59% | 0.03 28.48% | 0.03 18.87% | ||
capex to revenue | -0.02 - | -0.16 754.25% | -0.23 46.65% | -0.13 44.69% | -0.06 55.83% | -0.55 867.54% | -0.14 74.17% | |||
cash per share | 51.49 - | 21.52 58.21% | 16.36 23.96% | 42.77 161.43% | 34.51 19.31% | 11.58 66.45% | 6.19 46.57% | 11.28 82.26% | 0.01 99.94% | |
days of inventory on hand | 70.84 - | 89.75 26.69% | 122.15 36.10% | 48.60 60.21% | 76.36 57.12% | 22.23 70.88% | 73.08 228.67% | |||
days payables outstanding | 161.73 - | 143.60 11.21% | 155.37 8.20% | 100.63 35.23% | 85.57 14.97% | 199.39 133.01% | 468.23 134.84% | |||
days sales outstanding | 45.41 - | 23.18 48.96% | 27.95 20.59% | 30.99 10.89% | 24.14 22.12% | 975.02 3,939.82% | 83.27 91.46% | |||
debt to assets | 0.03 - | 0.20 - | 0.10 49.65% | 0.04 55.10% | 0.09 92.62% | 0.22 160.61% | 0.02 91.86% | 0.03 73.33% | ||
debt to equity | 0.03 - | 0.29 - | 0.13 56.22% | 0.06 56.82% | 0.11 104.59% | 1.96 1,632.54% | 0.03 98.64% | -0.42 1,684.62% | ||
dividend yield | ||||||||||
earnings yield | -0.17 - | -0.19 8.45% | -0.35 86.24% | -0.20 41.93% | -0.44 116.64% | -0.79 77.10% | -1.31 67.08% | -0.40 69.77% | -0.01 96.28% | |
enterprise value | 41.74M - | 67.61M 61.97% | 58.43M 13.57% | 112.48M 92.49% | 71.25M 36.65% | 32.58M 54.28% | 37.64M 15.53% | 64.69M 71.88% | 1.77B 2,643.99% | |
enterprise value over ebitda | -10.18 - | -5.26 48.37% | -2.58 50.95% | -5.00 93.97% | -1.97 60.55% | -1.26 36.28% | -1.12 10.75% | -2.11 88.21% | -73.14 3,363.00% | |
ev to operating cash flow | -6.16 - | -6.54 6.25% | -2.76 57.78% | -7.43 169.16% | -2.18 70.65% | -1.64 24.92% | -1.80 9.92% | -1.71 4.92% | -68.53 3,903.11% | |
ev to sales | 9.03 - | 8.60 4.68% | 4.72 45.11% | 1.47 68.81% | 2.28 54.58% | 29.29 1,186.14% | 373.21 1,174.29% | |||
free cash flow per share | -159.89 - | -54.50 65.92% | -85.12 56.20% | -42.52 50.04% | -64.82 52.43% | -29.90 53.87% | -19.72 34.06% | -18.94 3.92% | -0.18 99.06% | |
free cash flow yield | -0.36 - | -0.14 59.86% | -0.39 167.76% | -0.14 64.24% | -0.41 198.09% | -0.61 48.18% | -0.58 4.80% | -0.45 22.96% | -0.01 96.65% | |
graham net net | 23.53 - | 7.03 70.13% | -29.36 517.81% | 17.29 158.89% | 18.11 4.73% | -0.73 104.02% | -16.37 2,148.62% | 7.50 145.81% | -0.06 100.82% | |
graham number | 450.64 - | 281.20 37.60% | 420.57 49.56% | 372.23 11.49% | 362.55 2.60% | 202.59 44.12% | 56.26 72.23% | 68.93 22.52% | 0.15 99.79% | |
income quality | 0.83 - | 0.76 8.39% | 1.09 42.95% | 0.59 45.57% | 0.84 41.30% | 0.68 18.95% | 0.42 37.63% | 0.82 94.83% | 0.98 18.64% | |
intangibles to total assets | 0.64 - | 0.64 1.31% | 0.68 5.94% | 0.45 33.48% | 0.36 21.27% | 0.39 9.80% | 0.23 40.89% | 0 100% | 0 | |
interest coverage | -0.51 - | -117.56 - | -107.18 8.83% | -250.14 133.39% | -235.51 5.85% | -233.22 0.97% | -4.82K 1,968.12% | -567.90 88.23% | ||
interest debt per share | 86.22 - | 30.45 - | 13.08 57.03% | 4.91 62.48% | 5.52 12.50% | 6.33 14.68% | 0.34 94.64% | 0.00 99.24% | ||
inventory turnover | 5.15 - | 4.07 21.07% | 2.99 26.52% | 7.51 151.33% | 4.78 36.35% | 16.42 243.45% | 4.99 69.57% | |||
invested capital | 0.03 - | 0.29 - | 0.13 56.22% | 0.06 56.82% | 0.11 104.59% | 1.96 1,632.54% | 0.03 98.64% | -0.42 1,684.62% | ||
market cap | 46.72M - | 71.69M 53.44% | 55.13M 23.10% | 124.74M 126.27% | 87.94M 29.50% | 37.31M 57.58% | 37.63M 0.87% | 87.22M 131.76% | 1.78B 1,936.04% | |
net current asset value | 2.48M - | 1.40M 43.48% | -5.44M 487.25% | 9.61M 276.70% | 14.12M 46.97% | 2.07M 85.31% | -14.85M 816.00% | 22.79M 253.50% | -2.47M 110.82% | |
net debt to ebitda | 1.22 - | 0.32 73.89% | -0.15 146.00% | 0.55 473.44% | 0.46 15.20% | 0.18 60.48% | -0.00 100.05% | 0.74 791,033.87% | 0.03 95.86% | |
net income per share | -77.72 - | -71.56 7.92% | -77.75 8.64% | -63.06 18.89% | -69.86 10.78% | -38.52 44.87% | -44.57 15.72% | -16.80 62.30% | -0.17 98.96% | |
operating cash flow per share | -64.61 - | -54.50 15.65% | -84.64 55.31% | -37.37 55.85% | -58.49 56.53% | -26.13 55.32% | -18.86 27.83% | -18.35 2.72% | -0.17 99.06% | |
payables turnover | 2.26 - | 2.54 12.63% | 2.35 7.58% | 3.63 54.39% | 4.27 17.60% | 1.83 57.08% | 0.78 57.42% | |||
receivables turnover | 8.04 - | 15.75 95.92% | 13.06 17.07% | 11.78 9.82% | 15.12 28.41% | 0.37 97.52% | 4.38 1,070.94% | |||
research and ddevelopement to revenue | 1.50 - | 0.58 61.56% | 1.25 116.37% | 0.47 62.33% | 0.50 6.78% | 5.10 917.73% | 2.18 57.20% | |||
return on tangible assets | -1.48 - | -3.16 113.49% | -1.62 48.78% | -0.91 43.80% | -1.04 14.33% | -1.01 3.07% | -2.08 106.65% | -0.90 56.63% | -2.40 165.30% | |
revenue per share | 25.89 - | 32.28 24.66% | 27.02 16.30% | 29.06 7.56% | 14.91 48.68% | 1.07 92.81% | 0.03 97.04% | |||
roe | -0.67 - | -1.46 117.75% | -0.77 47.23% | -0.65 16.01% | -0.84 29.36% | -0.81 2.65% | -14.12 1,636.48% | -1.34 90.53% | 32.42 2,525.35% | |
roic | -0.72 - | -1.49 107.33% | -0.62 58.01% | -0.55 12.17% | -0.79 44.69% | -0.69 12.94% | -3.11 350.86% | -1.18 62.23% | 203.84 17,431.48% | |
sales general and administrative to revenue | ||||||||||
shareholders equity per share | 116.14 - | 49.11 57.71% | 101.12 105.89% | 97.65 3.43% | 83.62 14.37% | 47.36 43.36% | 3.16 93.34% | 12.57 298.20% | -0.01 100.04% | |
stock based compensation to revenue | 0.73 - | 0.46 36.95% | 0.43 6.52% | 0.27 38.75% | 0.27 0.79% | 0.90 235.69% | -0.07 107.97% | |||
tangible asset value | 2.58M - | 1.55M 39.95% | -496.80K 132.11% | 16.22M 3,364.94% | 25.84M 59.31% | 17.27M 33.17% | -3.66M 121.20% | 25.88M 807.07% | -808.07K 103.12% | |
tangible book value per share | 24.55 - | 8.16 66.77% | -1.99 124.36% | 40.05 2,115.53% | 46.28 15.55% | 22.70 50.96% | -3.30 114.56% | 12.57 480.47% | -0.01 100.04% | |
working capital | 2.48M - | 1.40M 43.48% | -1.54M 209.75% | 12.67M 922.62% | 14.23M 12.28% | 3.67M 74.23% | -7.40M 301.85% | 23.98M 423.99% | -2.12M 108.86% |
All numbers in USD (except ratios and percentages)